ISRAEL DAYBOOK: Teva Profit Rises on Cephalon Purchase
(Corrects name of company in first paragraph.)
Teva Pharmaceutical Industries Ltd. (TEVA) said fourth-quarter profit rose 23 percent, boosted by last year’s acquisition of U.S. drugmaker Cephalon Inc.
Earnings excluding some costs climbed to $1.4 billion, or $1.59 a share, from $1.1 billion, or $1.25, a year earlier, the Petach Tikva, Israel-based company said in a statement today. Profit matched the average estimate of $1.59 a share from 25 analysts surveyed by Bloomberg.
WHAT TO WATCH: * The Central Bureau of Statistics will release consumer price index data for January at 6:30 p.m. in Jerusalem. * The Institute for National Security Studies is scheduled to hold a panel on: “Israel and the US: National Security Challenges and their Influence on Bilateral Relations” at 4 p.m. in Jerusalem. EQUITY MOVERS: * Nice Systems Ltd. (NICE IT), the maker of digital surveillance and monitoring systems will probably report adjusted net income of $133 million for 2011, according to the median estimate of six analysts surveyed by Bloomberg. * Nova Measuring Instruments Ltd. (NVMI IT), a maker of monitoring systems for the semiconductor manufacturing industry, is scheduled to release fourth-quarter results. * Delek Real Estate Ltd. (DLKR IT) Series Heh bondholders of the property company owned by Isaac Tshuva didn’t approve a request for a delay in interest payments. MARKETS: * The TA-25 Index fell 0.6 percent to 1,112.64. * The yield on the Mimshal Shiklit government bond due January 2022 was at 4.6 percent. * The shekel gained 0.3 percent to 3.7290 a dollar at 8:22 a.m. in Tel Aviv. * Corn for March delivery rose 0.2 percent to $6.3475 a bushel. * Crude oil for March delivery increased 0.9 percent to $101.60 a barrel. * Gold for immediate delivery advanced 0.4 percent to $1,726.38 an ounce.
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.